Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KTTA

Pasithea Therapeutics Corp

May 08 • 10:38AM ET

0.8300

-0.0100 -1.19 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: NRXP NERV ADIL ALZN DMAC

| Held by: PSIL VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.57	Insider Own	12.28%	Shs Outstand	23.09M	Perf Week	-1.31%
Market Cap	20.70M	Forward P/E	-	EPS next Y	-2.10	Insider Trans	6.99%	Shs Float	21.88M	Perf Month	15.28%
Enterprise Value	-34.56M	PEG	-	EPS next Q	-0.45	Inst Own	73.79%	Short Float	1.04%	Perf Quarter	14.48%
Income	-20.43M	P/S	-	EPS this Y	36.08%	Inst Trans	29.87%	Short Ratio	0.55	Perf Half Y	13.02%
Sales	0.00M	P/B	0.35	EPS next Y	-12.90%	ROA	-53.54%	Short Interest	0.23M	Perf YTD	-35.66%
Book/sh	2.39	P/C	0.37	EPS next 5Y	7.54%	ROE	-58.36%	52W High	2.06 -59.71%	Perf Year	-13.54%
Cash/sh	2.22	P/FCF	-	EPS past 3/5Y	35.92% -117.71%	ROIC	-36.99%	52W Low	0.28 195.37%	Perf 3Y	-88.29%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	12.43% 8.82%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	71.88%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.35	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	60.54	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	11.35	EPS Q/Q	63.00%	SMA20	10.15%	Beta	0.24	Target Price	3.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	7.10%	Rel Volume	0.43	Prev Close	0.84
Employees	5	LT Debt/Eq	0.00	Earnings	Feb 25	SMA200	1.83%	Avg Volume	410.90K	Price	0.83
IPO	Sep 15, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-338.89% -	Trades		Volume	37,903	Change	-1.19%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)